HomepageMedicineFDA Clears AnX Robotica’s NaviCam SB for Expanded Indications Medicine FDA Clears AnX Robotica’s NaviCam SB for Expanded Indications admin Posted on January 16, 2024 The device can produce AI-assisted readings. LEAVE A RESPONSE Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. admin View all posts Post navigation Previous PostInvestments from America in Indian real estate fall 39 per centpc to $USD 1.35 bn last year: JLL Next PostBest Red Carpet Fashion At the Emmys: Suki Waterhouse, Jennifer Coolidge & More You Might Also Like Medicine FDA Fast Tracks Candel Therapeutics’ Novel Treatment for Pancreatic Ductal Adenocarcinoma admin January 3, 2024 Medicine FDA’s Oncologic Drugs Advisory Committee Recommends Earlier Treatment with Carvykti for Relapsed or Refractory Multiple Myeloma admin March 19, 2024 Medicine Viking Therapeutics Presents Positive Data from VK2735 for Reducing Body Weight Effectively and Safely admin November 5, 2024 Medicine FDA Hands Expanded Indication to Gilead’s Vemlidy for Chronic HBV Infection in Pediatric Patients admin March 30, 2024
Medicine FDA Fast Tracks Candel Therapeutics’ Novel Treatment for Pancreatic Ductal Adenocarcinoma admin January 3, 2024
Medicine FDA’s Oncologic Drugs Advisory Committee Recommends Earlier Treatment with Carvykti for Relapsed or Refractory Multiple Myeloma admin March 19, 2024
Medicine Viking Therapeutics Presents Positive Data from VK2735 for Reducing Body Weight Effectively and Safely admin November 5, 2024
Medicine FDA Hands Expanded Indication to Gilead’s Vemlidy for Chronic HBV Infection in Pediatric Patients admin March 30, 2024